BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24821064)

  • 41. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.
    Baenke F; Dubuis S; Brault C; Weigelt B; Dankworth B; Griffiths B; Jiang M; Mackay A; Saunders B; Spencer-Dene B; Ros S; Stamp G; Reis-Filho JS; Howell M; Zamboni N; Schulze A
    J Pathol; 2015 Oct; 237(2):152-65. PubMed ID: 25965974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis.
    Kim HK; Lee I; Bang H; Kim HC; Lee WY; Yun SH; Lee J; Lee SJ; Park YS; Kim KM; Kang WK
    Mol Cancer Ther; 2018 Apr; 17(4):838-848. PubMed ID: 29483215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.
    Martins D; Beça FF; Sousa B; Baltazar F; Paredes J; Schmitt F
    Cell Cycle; 2013 Aug; 12(16):2684-90. PubMed ID: 23907124
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.
    Whitaker-Menezes D; Martinez-Outschoorn UE; Lin Z; Ertel A; Flomenberg N; Witkiewicz AK; Birbe RC; Howell A; Pavlides S; Gandara R; Pestell RG; Sotgia F; Philp NJ; Lisanti MP
    Cell Cycle; 2011 Jun; 10(11):1772-83. PubMed ID: 21558814
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues.
    Choi MG; Sohn TS; Park SB; Paik YH; Noh JH; Kim KM; Park CK; Kim S
    Eur Surg Res; 2009; 42(4):223-9. PubMed ID: 19279387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced Krüppel-like factor 17 (KLF17) expression correlates with poor survival in patients with gastric cancer.
    Peng JJ; Wu B; Xiao XB; Shao YS; Feng Y; Yin MX
    Arch Med Res; 2014 Jul; 45(5):394-9. PubMed ID: 24947617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer.
    Johnson JM; Lai SY; Cotzia P; Cognetti D; Luginbuhl A; Pribitkin EA; Zhan T; Mollaee M; Domingo-Vidal M; Chen Y; Campling B; Bar-Ad V; Birbe R; Tuluc M; Martinez Outschoorn U; Curry J
    Semin Oncol; 2015 Dec; 42(6):915-22. PubMed ID: 26615136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased expression of pleiotrophin is a prognostic marker for patients with gastric cancer.
    Hu H; Li C; Cai S; Zhu C; Tian Y; Zheng J; Hu J; Chen C; Liu W
    Hepatogastroenterology; 2014; 61(133):1478-82. PubMed ID: 25436328
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The net acid extruders NHE1, NBCn1 and MCT4 promote mammary tumor growth through distinct but overlapping mechanisms.
    Andersen AP; Samsøe-Petersen J; Oernbo EK; Boedtkjer E; Moreira JMA; Kveiborg M; Pedersen SF
    Int J Cancer; 2018 Jun; 142(12):2529-2542. PubMed ID: 29363134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis.
    Bovenzi CD; Hamilton J; Tassone P; Johnson J; Cognetti DM; Luginbuhl A; Keane WM; Zhan T; Tuluc M; Bar-Ad V; Martinez-Outschoorn U; Curry JM
    Biomed Res Int; 2015; 2015():242437. PubMed ID: 26779534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
    Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J
    Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ectopic expression of B and T lymphocyte attenuator in gastric cancer: a potential independent prognostic factor in patients with gastric cancer.
    Feng XY; Wen XZ; Tan XJ; Hou JH; Ding Y; Wang KF; Dong J; Zhou ZW; Chen YB; Zhang XS
    Mol Med Rep; 2015 Jan; 11(1):658-64. PubMed ID: 25334051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of human tissue kallikrein-related peptidases 6 and 10 in gastric cancer.
    Kolin DL; Sy K; Rotondo F; Bassily MN; Kovacs K; Brezden-Masley C; Streutker CJ; Yousef GM
    Biol Chem; 2014 Sep; 395(9):1087-93. PubMed ID: 25153389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pilot study demonstrating metabolic and anti-proliferative effects of in vivo anti-oxidant supplementation with N-Acetylcysteine in Breast Cancer.
    Monti D; Sotgia F; Whitaker-Menezes D; Tuluc M; Birbe R; Berger A; Lazar M; Cotzia P; Draganova-Tacheva R; Lin Z; Domingo-Vidal M; Newberg A; Lisanti MP; Martinez-Outschoorn U
    Semin Oncol; 2017 Jun; 44(3):226-232. PubMed ID: 29248134
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PTK7 as a novel marker for favorable gastric cancer patient survival.
    Lin Y; Zhang LH; Wang XH; Xing XF; Cheng XJ; Dong B; Hu Y; Du H; Li YA; Zhu YB; Ding N; Du YX; Li JY; Ji JF
    J Surg Oncol; 2012 Dec; 106(7):880-6. PubMed ID: 22585737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The relationship between the expressions of tumor associated fibroblasts Cav-1 and MCT4 and the prognosis of papillary carcinoma of breast.
    Zhai Y; Chai L; Chen J
    Pak J Pharm Sci; 2017 Jan; 30(1 Suppl):263-272. PubMed ID: 28625953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies.
    Baek G; Tse YF; Hu Z; Cox D; Buboltz N; McCue P; Yeo CJ; White MA; DeBerardinis RJ; Knudsen ES; Witkiewicz AK
    Cell Rep; 2014 Dec; 9(6):2233-49. PubMed ID: 25497091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Programmed Death-1 Ligand-1 (PDL1) Expression Is Associated with the Prognosis of Patients with Stage II/III Gastric Cancer.
    Tamura T; Ohira M; Tanaka H; Muguruma K; Toyokawa T; Kubo N; Sakurai K; Amano R; Kimura K; Shibutani M; Maeda K; Hirakawa K
    Anticancer Res; 2015 Oct; 35(10):5369-76. PubMed ID: 26408698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinico-pathological significance of exosome marker CD63 expression on cancer cells and stromal cells in gastric cancer.
    Miki Y; Yashiro M; Okuno T; Kuroda K; Togano S; Hirakawa K; Ohira M
    PLoS One; 2018; 13(9):e0202956. PubMed ID: 30222750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunohistochemical expression and localization of cytokines/chemokines/growth factors in gastric cancer.
    Raja UM; Gopal G; Shirley S; Ramakrishnan AS; Rajkumar T
    Cytokine; 2017 Jan; 89():82-90. PubMed ID: 27793525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.